Total Visits

Views
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy2195

Total Visits Per Month

October 2023November 2023December 2023January 2024February 2024March 2024April 2024
Newly designed hemagglutinin-Der p 2 chimera is a potential candidate for allergen specific immunotherapy01091215083920

File Visits

Views
512.pdf231

Top country views

Views
United States164
Sweden11
Serbia5
Iran4
Germany3
Tajikistan1

Top cities views

Views
Ashburn7
Belgrade5
Des Moines1
Dushanbe1
Rockville1